200 related articles for article (PubMed ID: 28594575)
1. Bolus Calculator Reduces Hypoglycemia in the Short Term and Fear of Hypoglycemia in the Long Term in Subjects with Type 1 Diabetes (CBMDI Study).
Vallejo Mora MDR; Carreira M; Anarte MT; Linares F; Olveira G; González Romero S
Diabetes Technol Ther; 2017 Jul; 19(7):402-409. PubMed ID: 28594575
[TBL] [Abstract][Full Text] [Related]
2. Comparison of treatment with continuous subcutaneous insulin infusion versus multiple daily insulin injections with bolus calculator in patients with type 1 diabetes.
Pérez-García L; Goñi-Iriarte MJ; García-Mouriz M
Endocrinol Nutr; 2015; 62(7):331-7. PubMed ID: 26234808
[TBL] [Abstract][Full Text] [Related]
3. The Calculating Boluses on Multiple Daily Injections (CBMDI) study: A randomized controlled trial on the effect on metabolic control of adding a bolus calculator to multiple daily injections in people with type 1 diabetes.
Vallejo-Mora MD; Carreira-Soler M; Linares-Parrado F; Olveira G; Rojo-Martínez G; Domínguez-López M; Ruiz-de-Adana-Navas MS; González-Romero MS
J Diabetes; 2017 Jan; 9(1):24-33. PubMed ID: 26848934
[TBL] [Abstract][Full Text] [Related]
4. Bolus calculator and wirelessly communicated blood glucose measurement effectively reduce hypoglycaemia in type 1 diabetic children - randomized controlled trial.
Ramotowska A; Szypowska A
Diabetes Metab Res Rev; 2014 Feb; 30(2):146-53. PubMed ID: 24115314
[TBL] [Abstract][Full Text] [Related]
5. The Use of a Smart Bolus Calculator Informed by Real-time Insulin Sensitivity Assessments Reduces Postprandial Hypoglycemia Following an Aerobic Exercise Session in Individuals With Type 1 Diabetes.
Fabris C; Nass RM; Pinnata J; Carr KA; Koravi CLK; Barnett CL; Oliveri MC; Anderson SM; Chernavvsky DR; Breton MD
Diabetes Care; 2020 Apr; 43(4):799-805. PubMed ID: 32144167
[TBL] [Abstract][Full Text] [Related]
6. Use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in patients with type 1 diabetes mellitus treated with multiple daily insulin injections.
Barnard K; Parkin C; Young A; Ashraf M
J Diabetes Sci Technol; 2012 Jan; 6(1):144-9. PubMed ID: 22401332
[TBL] [Abstract][Full Text] [Related]
7. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
[TBL] [Abstract][Full Text] [Related]
8. Long-term metabolic effects of continuous subcutaneous insulin infusion therapy in type 1 diabetes.
Cohen ND; Hong ES; Van Drie C; Balkau B; Shaw J
Diabetes Technol Ther; 2013 Jul; 15(7):544-9. PubMed ID: 23617252
[TBL] [Abstract][Full Text] [Related]
9. Continuous subcutaneous insulin infusion vs modern multiple injection regimens in type 1 diabetes: an updated meta-analysis of randomized clinical trials.
Pala L; Dicembrini I; Mannucci E
Acta Diabetol; 2019 Sep; 56(9):973-980. PubMed ID: 30945047
[TBL] [Abstract][Full Text] [Related]
10. Multicenter, open-label, nonrandomized, observational safety study in subjects using insulin aspart in basal-bolus regimen for the treatment of diabetes.
Krzymień J; Kobli T; Nazar M
Pol Arch Med Wewn; 2010 Nov; 120(11):444-50. PubMed ID: 21102380
[TBL] [Abstract][Full Text] [Related]
11. Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study.
Charleer S; De Block C; Nobels F; Radermecker RP; Lowyck I; Mullens A; Scarnière D; Spincemaille K; Strivay M; Weber E; Taes Y; Vercammen C; Keymeulen B; Mathieu C; Gillard P;
Diabetes Care; 2020 Dec; 43(12):3016-3023. PubMed ID: 33067260
[TBL] [Abstract][Full Text] [Related]
12. Effect of Automated Bolus Calculation on Glucose Variability and Quality of Life in Patients With Type 1 Diabetes on CSII Treatment.
van Meijel LA; van den Heuvel-Bens SP; Zimmerman LJ; Bazelmans E; Tack CJ; de Galan BE
Clin Ther; 2018 Jun; 40(6):862-871. PubMed ID: 29502804
[TBL] [Abstract][Full Text] [Related]
13. Reduction in Hypoglycemia With the Predictive Low-Glucose Management System: A Long-term Randomized Controlled Trial in Adolescents With Type 1 Diabetes.
Abraham MB; Nicholas JA; Smith GJ; Fairchild JM; King BR; Ambler GR; Cameron FJ; Davis EA; Jones TW;
Diabetes Care; 2018 Feb; 41(2):303-310. PubMed ID: 29191844
[TBL] [Abstract][Full Text] [Related]
14. Fear of hypoglycemia in type 1 diabetes managed by continuous subcutaneous insulin infusion: is it associated with poor glycemic control?
Nixon R; Pickup JC
Diabetes Technol Ther; 2011 Feb; 13(2):93-8. PubMed ID: 21284474
[TBL] [Abstract][Full Text] [Related]
15. Clinical Safety and Feasibility of the Advanced Bolus Calculator for Type 1 Diabetes Based on Case-Based Reasoning: A 6-Week Nonrandomized Single-Arm Pilot Study.
Reddy M; Pesl P; Xenou M; Toumazou C; Johnston D; Georgiou P; Herrero P; Oliver N
Diabetes Technol Ther; 2016 Aug; 18(8):487-93. PubMed ID: 27196358
[TBL] [Abstract][Full Text] [Related]
16. Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
Lind M; Polonsky W; Hirsch IB; Heise T; Bolinder J; Dahlqvist S; Schwarz E; Ólafsdóttir AF; Frid A; Wedel H; Ahlén E; Nyström T; Hellman J
JAMA; 2017 Jan; 317(4):379-387. PubMed ID: 28118454
[TBL] [Abstract][Full Text] [Related]
17. Comparison between a multiple daily insulin injection regimen (basal once-daily glargine plus mealtime lispro) and continuous subcutaneous insulin infusion (lispro) using continuous glucose monitoring in metabolically optimized type 1 diabetes patients: A randomized open-labelled parallel study.
Ruiz-de-Adana MS; Dominguez-Lopez ME; Gonzalez-Molero I; Machado A; Martin V; Cardona I; de-la-Higuera M; Tapia MJ; Soriguer F; Anarte MT; Rojo-Martínez G
Med Clin (Barc); 2016 Mar; 146(6):239-46. PubMed ID: 26656958
[TBL] [Abstract][Full Text] [Related]
18. Association of Insulin Pump Therapy vs Insulin Injection Therapy With Severe Hypoglycemia, Ketoacidosis, and Glycemic Control Among Children, Adolescents, and Young Adults With Type 1 Diabetes.
Karges B; Schwandt A; Heidtmann B; Kordonouri O; Binder E; Schierloh U; Boettcher C; Kapellen T; Rosenbauer J; Holl RW
JAMA; 2017 Oct; 318(14):1358-1366. PubMed ID: 29049584
[TBL] [Abstract][Full Text] [Related]
19. Impact of the "Diabetes Interactive Diary" telemedicine system on metabolic control, risk of hypoglycemia, and quality of life: a randomized clinical trial in type 1 diabetes.
Rossi MC; Nicolucci A; Lucisano G; Pellegrini F; Di Bartolo P; Miselli V; Anichini R; Vespasiani G;
Diabetes Technol Ther; 2013 Aug; 15(8):670-9. PubMed ID: 23844569
[TBL] [Abstract][Full Text] [Related]
20. Bolus calculator improves long-term metabolic control and reduces glucose variability in pump-treated patients with Type 1 diabetes.
Lepore G; Dodesini AR; Nosari I; Scaranna C; Corsi A; Trevisan R
Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):e15-6. PubMed ID: 22673770
[No Abstract] [Full Text] [Related]
[Next] [New Search]
